THE CANCER GENETIC COUNSELING BLOG PROVIDES THE LATEST GENETIC COUNSELING AND TESTING INFORMATION SO PEOPLE AT INCREASED RISK FOR HEREDITARY CANCER CAN MAKE INFORMED MEDICAL DECISIONS. THESE INTERVENTIONS CAN HAVE A HUGE IMPACT ON A PERSON'S LIFE BY ALLOWING THEM TO TAILOR THEIR HEALTH CARE AND REDUCE THEIR RISK OF DEVELOPING CANCER. THE BLOG DOES NOT NECESSARILY REFLECT THE OPINIONS OF YALE CANCER CENTER LEADERSHIP OR FACULTY, BUT IS WRITTEN BY AN INDIVIDUAL.
Monday, April 19, 2010
Myriad raises price of BRCA testing, again.
On April 1, 2010 - three days after a court ruling that invalidated Myriad's patents on the BRCA1 and BRCA2 genes (associated with hereditary breast and ovarian cancer) the company increased their prices for genetic testing. Old cost =$3,770. New cost = $4,040 for full sequencing plus rearrangement testing.